Brendan Smith
Stock Analyst at TD Cowen
(4.92)
# 213
Out of 5,078 analysts
277
Total ratings
58.3%
Success rate
36.4%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CERT Certara | Reiterated: Buy | $9 → $11 | $10.33 | +6.49% | 11 | Oct 13, 2026 | |
| DNA Ginkgo Bioworks Holdings | Reiterated: Hold | $9 → $11 | $9.99 | +10.11% | 15 | Oct 13, 2026 | |
| HALO Halozyme Therapeutics | Rated: Buy | $105 → $130 | $125.63 | +3.48% | 25 | Oct 13, 2026 | |
| SDGR Schrödinger | Rated: Buy | $20 → $31 | $23.80 | +30.25% | 13 | Oct 13, 2026 | |
| TKNO Alpha Teknova | Rated: Buy | $7 → $11 | $6.42 | +71.34% | 13 | Oct 13, 2026 | |
| TWST Twist Bioscience | Rated: Buy | $115 → $190 | $139.92 | +35.79% | 19 | Oct 13, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $410 → $420 | $392.15 | +7.10% | 8 | Oct 13, 2026 | |
| MRVI Maravai LifeSciences Holdings | Initiated Coverage: Buy | $9 | $7.32 | +22.95% | 1 | Oct 5, 2026 | |
| ABSI Absci | Reiterated: Buy | n/a | $9.18 | - | 11 | Sep 30, 2026 | |
| OABI OmniAb | Reiterated: Buy | $3 → $5 | $4.66 | +7.30% | 12 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.40 | - | 12 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.28 | +56.25% | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.49 | - | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.37 | - | 11 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.82 | - | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $33 | $36.50 | -9.59% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $5.59 | -10.55% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.70 | - | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $176.93 | +13.04% | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $1.50 | +33.33% | 10 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 | $27.17 | -92.64% | 1 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.78 | - | 7 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $58.02 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.41 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $9 | $9.70 | n/a | 6 | Nov 12, 2024 |
Certara
Oct 13, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $10.33
Upside: +6.49%
Ginkgo Bioworks Holdings
Oct 13, 2026
Reiterated: Hold
Price Target: $9 → $11
Current: $9.99
Upside: +10.11%
Halozyme Therapeutics
Oct 13, 2026
Rated: Buy
Price Target: $105 → $130
Current: $125.63
Upside: +3.48%
Schrödinger
Oct 13, 2026
Rated: Buy
Price Target: $20 → $31
Current: $23.80
Upside: +30.25%
Alpha Teknova
Oct 13, 2026
Rated: Buy
Price Target: $7 → $11
Current: $6.42
Upside: +71.34%
Twist Bioscience
Oct 13, 2026
Rated: Buy
Price Target: $115 → $190
Current: $139.92
Upside: +35.79%
West Pharmaceutical Services
Oct 13, 2026
Reiterated: Buy
Price Target: $410 → $420
Current: $392.15
Upside: +7.10%
Maravai LifeSciences Holdings
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $7.32
Upside: +22.95%
Absci
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.18
Upside: -
OmniAb
Aug 17, 2026
Reiterated: Buy
Price Target: $3 → $5
Current: $4.66
Upside: +7.30%
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.40
Upside: -
Aug 11, 2026
Reiterated: Hold
Price Target: $2
Current: $1.28
Upside: +56.25%
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.49
Upside: -
Aug 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.37
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.82
Upside: -
Aug 5, 2026
Reiterated: Hold
Price Target: $20 → $33
Current: $36.50
Upside: -9.59%
Aug 5, 2026
Reiterated: Hold
Price Target: $5
Current: $5.59
Upside: -10.55%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.70
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: $200
Current: $176.93
Upside: +13.04%
Jul 15, 2026
Downgraded: Hold
Price Target: $4 → $2
Current: $1.50
Upside: +33.33%
Jul 14, 2026
Downgraded: Hold
Price Target: $2
Current: $27.17
Upside: -92.64%
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.78
Upside: -
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $58.02
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $18.41
Upside: n/a
Nov 12, 2024
Reiterated: Hold
Price Target: $14 → $9
Current: $9.70
Upside: n/a